BIOTON S.A. (WSE:BIO)

BIOTON Statistics

Total Valuation

BIOTON has a market cap or net worth of PLN 378.66 million. The enterprise value is 422.95 million.

Market Cap	378.66M
Enterprise Value	422.95M

Important Dates

The next estimated earnings date is Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

BIOTON has 85.86 million shares outstanding.

Current Share Class	85.86M
Shares Outstanding	85.86M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.48%
Float	43.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.43
PB Ratio	0.64
P/TBV Ratio	1.03
P/FCF Ratio	16.79
P/OCF Ratio	11.75
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.08, with an EV/FCF ratio of 18.75.

EV / Earnings	-40.70
EV / Sales	1.60
EV / EBITDA	15.08
EV / EBIT	120.29
EV / FCF	18.75

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 0.08.

Current Ratio	1.14
Quick Ratio	0.37
Debt / Equity	0.08
Debt / EBITDA	1.63
Debt / FCF	2.03
Interest Coverage	0.51

Financial Efficiency

Return on equity (ROE) is -1.75% and return on invested capital (ROIC) is 0.34%.

Return on Equity (ROE)	-1.75%
Return on Assets (ROA)	0.28%
Return on Invested Capital (ROIC)	0.34%
Return on Capital Employed (ROCE)	0.54%
Revenue Per Employee	730,413
Profits Per Employee	-28,631
Employee Count	364
Asset Turnover	0.34
Inventory Turnover	1.79

Taxes

In the past 12 months, BIOTON has paid 5.69 million in taxes.

Income Tax	5.69M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +29.71% in the last 52 weeks. The beta is 0.22, so BIOTON's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	+29.71%
50-Day Moving Average	4.34
200-Day Moving Average	3.91
Relative Strength Index (RSI)	53.07
Average Volume (20 Days)	39,081

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIOTON had revenue of PLN 265.14 million and -10.39 million in losses. Loss per share was -0.12.

Revenue	265.14M
Gross Profit	76.30M
Operating Income	3.52M
Pretax Income	-4.70M
Net Income	-10.39M
EBITDA	22.64M
EBIT	3.52M
Loss Per Share	-0.12

Balance Sheet

The company has 1.41 million in cash and 45.70 million in debt, giving a net cash position of -44.29 million or -0.52 per share.

Cash & Cash Equivalents	1.41M
Total Debt	45.70M
Net Cash	-44.29M
Net Cash Per Share	-0.52
Equity (Book Value)	588.02M
Book Value Per Share	6.85
Working Capital	16.81M

Cash Flow

In the last 12 months, operating cash flow was 32.24 million and capital expenditures -9.68 million, giving a free cash flow of 22.55 million.

Operating Cash Flow	32.24M
Capital Expenditures	-9.68M
Free Cash Flow	22.55M
FCF Per Share	0.26

Margins

Gross margin is 28.78%, with operating and profit margins of 1.33% and -3.92%.

Gross Margin	28.78%
Operating Margin	1.33%
Pretax Margin	-1.77%
Profit Margin	-3.92%
EBITDA Margin	8.54%
EBIT Margin	1.33%
FCF Margin	8.51%

Dividends & Yields

BIOTON does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-2.74%
FCF Yield	5.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 14, 2014. It was a reverse split with a ratio of 0.01.

Last Split Date	Jan 14, 2014
Split Type	Reverse
Split Ratio	0.01

Scores

BIOTON has an Altman Z-Score of -0.59 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.59
Piotroski F-Score	5